黑龙江省药品监督管理局药品生产安全延伸检查（中药材GAP符合性）检查结果通告（2025年 第5号）

Core Points - The announcement details the compliance checks for traditional Chinese medicine (TCM) material production quality management standards in Heilongjiang Province, confirming that the inspected companies met the Good Agricultural Practices (GAP) requirements [3]. Group 1: Compliance Checks - The Heilongjiang Provincial Drug Administration conducted compliance checks on three companies: Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd., Harbin Fangsheng Pharmaceutical Technology Co., Ltd., and Qitaihe Kangcaotang Medicinal Materials Co., Ltd. [3] - The checks were carried out from October 24 to November 7, 2025, focusing on the cultivation bases of TCM materials [3]. Group 2: Companies Inspected - Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. had a cultivation area of 108 acres for Ginkgo biloba leaves, and the inspection results confirmed compliance [3]. - Harbin Fangsheng Pharmaceutical Technology Co., Ltd. had a cultivation area of 202 acres for Shuxue Ning injection, also confirming compliance [3]. - Qitaihe Kangcaotang Medicinal Materials Co., Ltd. cultivated ginseng and red ginseng with a total area of 765 acres, meeting the GAP requirements [3].